Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuan Pharmaceutical Group Qingyutang Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the publicly traded Fuan Pharmaceutical Group. Based in Chongqing, the company specializes in the research, development, and large-scale production of chemical active pharmaceutical ingredients (APIs) and finished dosage forms. Its primary focus lies in anti-infective agents, particularly cephalosporins and macrolides, where it maintains a significant market share in China. The company operates advanced GMP-certified facilities capable of producing sterile powders for injection, tablets, and capsules. Qingyutang is recognized as a key high-tech enterprise, contributing extensively to the group's portfolio in respiratory, cardiovascular, and digestive health therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuan Pharmaceutical Group Qingyutang Pharmaceutical.